New pill tested for mental health conditions
NCT ID NCT06494397
Summary
This study compared a new tablet called VHX-896 to an existing drug, iloperidone, in people with schizophrenia or bipolar I disorder. The main goal was to see if the new tablet gets into the bloodstream the same way as the old one. Researchers also checked how safe and tolerable both drugs were for the 26 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanda Investigational Site
Los Alamitos, California, 90720, United States
-
Vanda Investigational Site
Gaithersburg, Maryland, 20877, United States
-
Vanda Investigational Site
Marlton, New Jersey, 08053, United States
Conditions
Explore the condition pages connected to this study.